When it physically interacts with GSK3β to phosphorylate β-catenin, a well-characterized oncogene in liver cancer, the degradation of β-catenin is triggered to promote the growth of liver cancer cells (Liang et al. 2019). This evidence concerns the gene GSK3B and liver cancer.